GLP-1 and dual GIP/GLP-1 agonists in obese patients with HFpEF: a systematic review and meta-analysis of RCTs
Abstract Background Obesity-related heart failure with preserved ejection fraction (HFpEF) is characterized by impaired exercise tolerance and poor health status. Metabolic modulation using glucagon-like peptide-1 (GLP-1) receptor agonists and dual glucose-dependent insulinotropic polypeptide (GIP)/...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2026-03-01
|
| Col·lecció: | BMC Cardiovascular Disorders |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s12872-026-05808-7 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|